Cargando…

Multiple biomarkers predict disease severity, progression and mortality in COPD

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by multiple subtypes and variable disease progression. Blood biomarkers have been variably associated with subtype, severity, and disease progression. Just as combined clinical variables are more highly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zemans, Rachel L., Jacobson, Sean, Keene, Jason, Kechris, Katerina, Miller, Bruce E., Tal-Singer, Ruth, Bowler, Russell P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470282/ https://www.ncbi.nlm.nih.gov/pubmed/28610627 http://dx.doi.org/10.1186/s12931-017-0597-7

Ejemplares similares

Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
por: Bowler, Russell, et al.
Publicado: (2019)

Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD
por: Cruickshank-Quinn, Charmion I., et al.
Publicado: (2018)

Meta-analysis of peripheral blood gene expression modules for COPD phenotypes
por: Reinhold, Dominik, et al.
Publicado: (2017)

Identifying Protein–metabolite Networks Associated with COPD Phenotypes
por: Mastej, Emily, et al.
Publicado: (2020)

TreeKernel: interpretable kernel machine tests for interactions between -omics and clinical predictors with applications to metabolomics and COPD phenotypes
por: Carpenter, Charlie M., et al.
Publicado: (2023)

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
por: Dickens, Jennifer A, et al.
Publicado: (2011)

The value of blood cytokines and chemokines in assessing COPD
por: Bradford, Eric, et al.
Publicado: (2017)

Deep learning on graphs for multi-omics classification of COPD
por: Zhuang, Yonghua, et al.
Publicado: (2023)

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD – results from the ECLIPSE study
por: Sand, Jannie M. B., et al.
Publicado: (2016)

Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice
por: Cruickshank-Quinn, Charmion, et al.
Publicado: (2017)

Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE COPD cohort
por: Sand, Jannie M.B., et al.
Publicado: (2020)

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes
por: Carolan, Brendan J, et al.
Publicado: (2014)

PaIRKAT: A pathway integrated regression-based kernel association test with applications to metabolomics and COPD phenotypes
por: Carpenter, Charlie M., et al.
Publicado: (2021)

Plasma microfibrillar-associated protein 4 is not prognostic of emphysema progression but is associated with cardiovascular disease history and mortality in COPD patients
por: Johansson, Sofie Lock, et al.
Publicado: (2019)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
por: Lonergan, Mike, et al.
Publicado: (2020)

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

Gene and metabolite time-course response to cigarette smoking in mouse lung and plasma
por: Miller, Mikaela A., et al.
Publicado: (2017)

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort
por: Rønnow, Sarah R., et al.
Publicado: (2020)

Increased von Willebrand Factor Processing in COPD, Reflecting Lung Epithelium Damage, Is Associated with Emphysema, Exacerbations and Elevated Mortality Risk
por: Langholm, Lasse L, et al.
Publicado: (2020)

Identifying miRNA-mRNA Networks Associated With COPD Phenotypes
por: Zhuang, Yonghua, et al.
Publicado: (2021)

An Augmented High-Dimensional Graphical Lasso Method to Incorporate Prior Biological Knowledge for Global Network Learning
por: Zhuang, Yonghua, et al.
Publicado: (2022)

The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory Infections
por: Tal-Singer, Ruth, et al.
Publicado: (2023)

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
por: Celli, Bartolome, et al.
Publicado: (2021)

Metabolome Features of COPD: A Scoping Review
por: Godbole, Suneeta, et al.
Publicado: (2022)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
por: Sun, Wei, et al.
Publicado: (2016)

Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
por: Bihlet, Asger Reinstrup, et al.
Publicado: (2017)

Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale
por: Liang, Zhenyu, et al.
Publicado: (2021)

Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease
por: Duvoix, Annelyse, et al.
Publicado: (2013)

Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study
por: Tamaki, Kentaro, et al.
Publicado: (2021)

Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
por: Valvi, Deepa, et al.
Publicado: (2012)

Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma
por: Halper-Stromberg, Eitan, et al.
Publicado: (2019)

COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry
por: Leung, Janice M., et al.
Publicado: (2016)

Characterisation of COPD heterogeneity in the ECLIPSE cohort
por: Agusti, Alvar, et al.
Publicado: (2010)

It’s more than low BMI: prevalence of cachexia and associated mortality in COPD
por: McDonald, Merry-Lynn N., et al.
Publicado: (2019)

Frailty: A global measure of the multisystem impact of COPD
por: Gale, Nichola S, et al.
Publicado: (2018)

CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin
por: Keir, Holly R., et al.
Publicado: (2020)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_89kr7dik86uj1ukkba8t952t46